Evidence map›Paper›PMID 29461475›Full record

ArticleBrain sciences2018

Octodrine: New Questions and Challenges in Sport Supplements.

Valeria Catalani, Mariya Prilutskaya, Ahmed Al-Imam, Shanna Marrinan, Yasmine Elgharably, Mire Zloh, Giovanni Martinotti, Robert Chilcott, Ornella Corazza

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Valeria CatalaniResearch Centre for Topical Drug Delivery and Toxicology, University of Hertfordshire, Herts SP9 11FA, UK. v.catalani@herts.ac.uk.
Mariya PrilutskayaSemey State Medical University, Republican Scientific and Practical Center of Mental Health, Pavlodar 140002, Kazakhstan. R.chilcott@herts.ac.uk.
Ahmed Al-ImamFaculty of Medicine, University of Baghdad, Baghdad 10071, Iraq. mariyapril2407@gmail.com.ORCID 0000-0002-9099-316X
Shanna MarrinanParliamentary Office of Science and Technology, Houses of Parliament, London SW1A 0AA UK. tesla1452@gmail.com.ORCID 0000-0003-1846-9424
Yasmine ElgharablyNavy General Hospital, Cardiovascular department, Alexandria 21513, Egypt. marrinans@parliament.uk.
Mire ZlohDepartment of Pharmacy, Pharmacology and Clinical Science, University of Hertfordshire, Herts AL10 9AB UK. yasmine_elgharably@ymail.com.
Giovanni MartinottiDepartment of Neuroscience, Imaging and Clinical Sciences, "G.d'Annunzio" University, Chieti 66100 Italy. m.zloh@herts.ac.uk.ORCID 0000-0002-4848-2737
Robert ChilcottResearch Centre for Topical Drug Delivery and Toxicology, University of Hertfordshire, Herts SP9 11FA, UK. Giovanni.Martinotti@gmail.com.
Ornella CorazzaDepartment of Pharmacy, Pharmacology and Clinical Science, University of Hertfordshire, Herts AL10 9AB UK. o.corazza@herts.ac.uk.ORCID 0000-0001-7371-319X
University of Hertfordshire · GBParliament of United Kingdom · GBSemey Medical University · KZUniversity of Baghdad · IQUniversity of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ambredinanti-obesity agentsdimethylhexylamineDMHAfitnessnovel psychoactive substanceoctodrineperformance and image-enhancing drugsweight loss

Identifiers

PMID29461475
PMCPMC5836053
OpenAlexW2793644559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.